Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd. (PASW) Revenue
Annual & quarterly revenue history · segment & region breakdown
PASW · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsPing An Biomedical Co., Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 6.13% year-over-year from $0.09B in FY2024.
Revenue trend
2024 – 2021 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-09-30 | $0.09B | +$0.01B | +6.13% |
| 2023-09-30 | $0.08B | -$0.03B | -27.92% |
| 2022-09-30 | $0.11B | +$0.02B | +15.10% |
| 2021-09-30 | $0.10B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ping An Biomedical Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ping An Biomedical Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from Ping An Biomedical Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PASW revenue · 4 questionsPASW's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 6.13% year-over-year from $0.09B in FY2024.
▸ Source: FMP · Ping An Biomedical Co., Ltd. SEC filings · GAAP · Ping An Biomedical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026